Asthma control test and peak expiratory flow rate: independent pediatric asthma management tools

M Chan1, S Sitaraman, A Dosanjh

  • 1Department of Pediatrics, University of California School of Medicine, La Jolla, California, USA.

Insights

The Asthma Control Test (ACT) and peak expiratory flow rate (PEFR) are independent tools for managing pediatric asthma. Nasal symptoms did not correlate with asthma control or airway function in this study.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Asthma Management

Background:

  • Asthma management complexity necessitates validated assessment tools.
  • National Heart Lung Blood Institute guidelines recommend the Asthma Control Test (ACT), airway function, and quality of life assessments.
  • The independence of ACT and airway function measures in asthma management requires further investigation.

Purpose of the Study:

  • To determine if the Asthma Control Test (ACT) and peak expiratory flow rate (PEFR) are independent tools in pediatric asthma management.
  • To investigate the correlation between nasal symptoms and asthma control or airway function.
  • To analyze ACT and airway function results in a pediatric outreach clinic setting.

Main Methods:

  • Retrospective review of 45 patient visits at a pediatric respiratory clinic in an underserved area.
  • Inclusion criteria: ability to perform airway function tests and multiple provider visits.
  • Analysis of ACT scores (≤19 defined uncontrolled asthma) and % predicted PEFR, with sub-analysis for nasal symptoms.

Main Results:

  • Mean ACT score was 21 (±3.3), and mean PEFR was 87.4% (±11).
  • No significant correlation was found between ACT scores and PEFR measurements.
  • Nasal symptoms were not found to be more prevalent in patients with uncontrolled asthma or lower PEFR.

Conclusions:

  • The Asthma Control Test (ACT) and peak expiratory flow rate (PEFR) serve as distinct and independent parameters for managing pediatric asthma patients.
  • These findings support the use of both ACT and PEFR as separate tools in clinical practice.
  • Nasal symptom presence does not appear to influence asthma control or airway function measures in this population.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.